(The Lancet Countdown, ACOG Position Statement, AAP Policy Statement on Climate Change). Global warming, the gradual heating of Earth's surface, oceans and atmosphere, is caused by human activity, ...

ACOG directs clinicians to have an "upfront and thorough" conversation so patients know pain might occur and are offered options to manage that pain, such as a paracervical block. Tsevat ...

ACOG also advised using shared decision-making when determining the pain management strategy. ACOG released new recommendations on pain management for in-office uterine and cervical procedures ...

Dallas, Texas--(Newsfile Corp. - May 19, 2025) - Alpha Cognition Inc. (NASDAQ: ACOG): Stonegate Capital Partners updates their coverage on Alpha Cognition Inc. (NASDAQ: ACOG). Alpha Cognition ...

2. ACOG also advises the use of various pain management strategies for other procedures, including endometrial biopsy, hysteroscopy, intrauterine imaging and cervical biopsy. 3. The guidance ...

ACOG also recommends local anesthetics like lidocaine spray or cream for IUD insertions, and varying options for other procedures including more topical or injected anesthetics, NSAIDs like ...

Source Reference: Loeliger K, et al "Abortion access in a post-Dobbs Southeast USA: changing geospatial patterns, disparities, and the experience of traveling for care" ACOG 2025.

Other pain management options for procedures may include NSAIDs and other medications, such as misoprostol, according to ACOG. The guidelines also call on physicians to use pain relief options ...

Other pain management options for procedures may include NSAIDs and other medications, such as misoprostol, according to ACOG. The guidelines also call on physicians to use pain relief options even ...

Christopher Zahn, MD, chief of clinical practice and health equity and quality for ACOG, noted that pain management strategies have been shaped by limited and conflicting evidence, as well as ...

Alpha Cognition Inc. (ACOG) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.58. This compares to loss of $0.75 per share a year ago.